Plasma C-reactive protein levels are associated with improved outcome in ARDS
- PMID: 19411291
- PMCID: PMC2818414
- DOI: 10.1378/chest.08-2413
Plasma C-reactive protein levels are associated with improved outcome in ARDS
Abstract
Background: C-reactive protein (CRP) has been studied as a marker of systemic inflammation and outcome in a number of diseases, but little is known about its characteristics in ARDS. We sought to examine plasma levels of CRP in patients with ARDS and their relationship to outcome and measures of illness severity.
Methods: We measured CRP levels in 177 patients within 48 h of disease onset and tested the association of protein level with 60-day mortality, 28-day daily organ dysfunction scores, and number of ventilator-free days.
Results: We found that CRP levels were significantly lower in nonsurvivors when compared with survivors (p = 0.02). Mortality rate decreased with increasing CRP decile (p = 0.02). An increasing CRP level was associated with a significantly higher probability of survival at 60 days (p = 0.005). This difference persisted after adjustment for age and severity of illness in a multivariable model (p = 0.009). Multivariable models were also used to show that patients in the group with higher CRP levels had significantly lower organ dysfunction scores (p = 0.001) and more ventilator-free days (p = 0.02).
Conclusions: Increasing plasma levels of CRP within 48 h of ARDS onset are associated with improved survival, lower organ failure scores, and fewer days of mechanical ventilation. These data appear to be contrary to the established view that CRP is solely a marker of systemic inflammation.
Figures
Similar articles
-
Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever.BMC Pulm Med. 2015 Mar 14;15:22. doi: 10.1186/s12890-015-0015-1. BMC Pulm Med. 2015. PMID: 25888398 Free PMC article.
-
[Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jan;29(1):34-38. doi: 10.3760/cma.j.issn.2095-4352.2017.01.008. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28459401 Chinese.
-
Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome.Crit Care Med. 2008 Aug;36(8):2322-7. doi: 10.1097/CCM.0b013e318181040d. Crit Care Med. 2008. PMID: 18596623 Free PMC article. Clinical Trial.
-
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.Crit Care Med. 2009 May;37(5):1594-603. doi: 10.1097/CCM.0b013e31819fb507. Crit Care Med. 2009. PMID: 19325471 Review.
-
Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.BMJ. 2008 May 3;336(7651):1006-9. doi: 10.1136/bmj.39537.939039.BE. Epub 2008 Apr 23. BMJ. 2008. PMID: 18434379 Free PMC article. Review.
Cited by
-
Association of C-reactive protein with mortality in Covid-19 patients: a secondary analysis of a cohort study.Sci Rep. 2023 Nov 21;13(1):20361. doi: 10.1038/s41598-023-47680-x. Sci Rep. 2023. PMID: 37990060 Free PMC article.
-
Interpretable Machine Learning for COVID-19: An Empirical Study on Severity Prediction Task.IEEE Trans Artif Intell. 2021 Jun 25;4(4):764-777. doi: 10.1109/TAI.2021.3092698. eCollection 2023 Aug. IEEE Trans Artif Intell. 2021. PMID: 37954545 Free PMC article.
-
Circulatory HMGB1 is an early predictive and prognostic biomarker of ARDS and mortality in a swine model of polytrauma.Front Immunol. 2023 Jul 14;14:1227751. doi: 10.3389/fimmu.2023.1227751. eCollection 2023. Front Immunol. 2023. PMID: 37520569 Free PMC article.
-
A Systematic Review and Meta-Analysis of Independent Predictors for Acute Respiratory Distress Syndrome in Patients Presenting With Sepsis.Cureus. 2023 Apr 3;15(4):e37055. doi: 10.7759/cureus.37055. eCollection 2023 Apr. Cureus. 2023. PMID: 37143620 Free PMC article. Review.
-
Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.Infect Chemother. 2022 Dec;54(4):674-698. doi: 10.3947/ic.2022.0172. Infect Chemother. 2022. PMID: 36596680 Free PMC article. Review.
References
-
- Okamura JM, Miyagi JM, Terada K, et al. Potential clinical applications of C-reactive protein. J Clin Lab Anal. 1990;4:231–235. - PubMed
-
- Blackburn WD., Jr Validity of acute phase proteins as markers of disease activity. J Rheumatol Suppl. 1994;42:9–13. - PubMed
-
- Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol. 2006;72:69–80. - PubMed
-
- Chung JL, Kong MS, Lin SL, et al. Diagnostic value of C-reactive protein in children with perforated appendicitis. Eur J Pediatr. 1996;155:529–531. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
